Project Grant 2051900
- This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
- The National Science Foundation awarded Cytorecovery Inc. a $255,986 Small Business Technology Transfer Phase I Project Grant under the Engineering program (CFDA 47.041) on March 15, 2021. The grant funded the development of on-chip integration of sample preparation and monitoring capabilities with dielectrophoretic cell isolation techniques. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award...
- Cision Vision, Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041) to develop a novel, label-free imaging device for real-time detection of lymph nodes during laparoscopic cancer surgeries. The one-year project period runs from December 1, 2021 to November 30, 2022 and is focused on delivering a new imaging technology to improve cancer surgery outcomes. The NSF Engineering...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Beken Bio, Inc. aims to develop a highly sensitive, minimally invasive laboratory test to detect early-stage ovarian cancer by assaying relevant biomarkers on circulating extracellular vesicles in patient plasma. The project will utilize a novel technology to identify key proteins in extracellular vesicles from various ovarian cancer subtypes and employ a machine...
- Federal Grant Award Summary Award Details: Avant Genomics, Inc. received a $305,000 Small Business Innovation Research (SBIR) Phase I Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on October 1, 2025, with completion targeted for September 30, 2026. Products/Services: The award funds development of an automated microfluidic-based system designed to streamline bisulfite conversion, a critical preparatory step in liquid...
- The National Science Foundation awarded a $275,000 Project Grant to Oraliva, Inc. under the Technology, Innovation, and Partnerships program to develop a portable, programmable single cell cytology platform for the early detection of epithelial cancers. The platform will combine microfluidics and artificial intelligence to classify potentially cancerous tissue in near real-time through multiparameter single-cell analysis and automated evaluation. The objectives are to link different clinical...
- The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Current Surgical Inc. from May 15, 2021 to November 30, 2021 under the Engineering program (CFDA 47.041). The grant funds the development of a smart needle for precise tumor ablation. The NSF Engineering program supports innovation, creativity, and excellence in engineering research and education to improve quality of life and economic strength. This award advances those goals by...
- Summary Innotech Precision Medicine, Inc., a woman-owned and minority-owned small business, received a $305,000 Project Grant from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on July 15, 2025. The award funds the development and validation of an integrated microfluidic diagnostic system designed to detect cancer biomarkers in saliva samples. The deliverables include a fully integrated microfluidic cartridge capable of...
- Federal Grant Award Summary Hidalga Technologies, LLC received a $304,935 Small Business Innovation Research (SBIR) Phase I Project Grant from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on October 1, 2025, with completion targeted for September 30, 2026. The company will develop and validate an artificial intelligence (AI)-driven platform designed to automate prior authorization (PA) processing workflows in oncology specialty...
The National Science Foundation Division of Industrial Innovation awarded Vynance Technologies, LLC $275,987 under the Engineering (47.041) federal grant program for its SBIR Phase I project titled "Cancer Diagnostic Tool Using Cancer Genomic Signatures to Determine Cancer Type." The award period runs from April 1, 2021 through December 31, 2021. Under this Project Grant, Vynance Technologies will develop a cancer diagnostic tool that analyzes cancer genomic signatures to determine the type of cancer present. The tool aims to improve cancer diagnosis and classification by leveraging genomic data. The Engineering program supports innovative research and education projects in all areas of engineering consistent with the NSF mission. This award advances the program's goals of enabling new technologies with potential economic and societal benefits.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $20.0k | 7/16/21 | ||
| Not listed | $256.0k | 2/18/21 |